Consumer Health/OTC Healthcare industry and market research, statistics, market share

Please ensure that JavaScript is enabled to view the full page

Filter Results

Total: (7)

by Product Type
- Reports (7)
  - Country Reports (7)
by Geography
by Date
- Last Year (7)

Filter Summary

Country Report

OTC Triptans in Germany

2011 saw the introduction of a second product in the category in Germany; Dolortriptan, with the active ingredient almotriptan, was introduced by Johnson & Johnson GmbH. This launch and the continued growth of Formigran (GlaxoSmithKline GmbH & Co KG)...

Jul 2012 | US$900| Add to cart | View details ›

Country Report

OTC Triptans in Sweden

The growing self-medication trend was a key driver of sales in 2011. OTC triptans products are most likely to be purchased by consumers who believe they are suffering from a migraine but who have not been diagnosed by a medical professional.

Jun 2012 | US$900| Add to cart | View details ›

Country Report

OTC Triptans in the United Kingdom

In 2011, sales of triptans were worth £6 million. Rising anxiety and stress levels caused by concerns over job and financial security are causing a rise in migraines and headaches in general. It is important for a pharmacist to distinguish between a ...

Jun 2012 | US$900| Add to cart | View details ›

Country Report

OTC Triptans in the Czech Republic

OTC triptans was only available via prescription in the Czech Republic in 2011 and there are no indications that such products will be made available OTC in the foreseeable future.

Apr 2012 | US$900| Add to cart | View details ›

Country Report

OTC Triptans in Russia

In 2011 all drugs classified as triptans remained Rx in Russia. Doctors can prescribe triptans to patients suffering from migraines if this diagnosis is approved. A switch to OTC is not expected, due to the specifics of the product and the known love...

Mar 2012 | US$900| Add to cart | View details ›

Country Report

OTC Triptans in Estonia

Triptans are only available as Rx medicine in Estonia. Triptans which are prescribed include Zolmitriptan Actavis 5mg (produced by Actavis Ltd), Imigran (produced by GlaxoSmithKline), Sumatriptan Sandoz (produced by Sandoz) and Cinie (produced by ...

Mar 2012 | US$900| Add to cart | View details ›

Country Report

OTC Triptans in New Zealand

In June 2006, sumatriptan was reclassified from a prescription medicine to a restricted medicine (sold by a pharmacist in a pharmacy). This reclassification applied to packs of no more than two 50mg tablets. As a result of this reclassification, ...

Mar 2012 | US$900| Add to cart | View details ›

Latest Analyst Insight for the Consumer Health Industry

Hain Celestial Reboots the Relaxation Drink With New “Sleep Shots” Line

Jan 2013

New “Maintenance of Blood Sugar” EU Claim Opens Door to Targeting Metabolic Syndrome

Jan 2013

Measuring Up Consumer Health in 2012

Jan 2013

market

Country Reports

Consumer Health in Algeria | Jul 2012
Consumer Health in Argentina | Mar 2012
Consumer Health in Australia | Feb 2012
Consumer Health in Austria | Jul 2012
Consumer Health in Azerbaijan | Feb 2012
Consumer Health in Belarus | Apr 2012
Consumer Health in Belgium | Jun 2012
Consumer Health in Bolivia | Mar 2012
Consumer Health in Bosnia-Herzegovina | May 2012
Consumer Health in Brazil | May 2012
Consumer Health in Bulgaria | Mar 2012
Consumer Health in Cameroon | May 2012
Consumer Health in Canada | Feb 2012
Consumer Health in Chile | Feb 2012
Consumer Health in China | Feb 2012
Consumer Health in Colombia | May 2012
Consumer Health in Costa Rica | Jun 2012
Consumer Health in Croatia | Oct 2012
Consumer Health in Denmark | Mar 2012
Consumer Health in Dominican Republic | May 2012
Consumer Health in Ecuador | Apr 2012
Consumer Health in Egypt | Nov 2012
Consumer Health in Estonia | Mar 2012
Consumer Health in Finland | May 2012
Consumer Health in France | Apr 2012
Consumer Health in Georgia | May 2012
Consumer Health in Germany | Jul 2012
Consumer Health in Greece | Jun 2012
Consumer Health in Guatemala | May 2012
Consumer Health in Hong Kong, China | Apr 2012
Consumer Health in Hungary | Jul 2012
Consumer Health in India | Jun 2012
Consumer Health in Indonesia | Feb 2012
Consumer Health in Iran | Aug 2012
Consumer Health in Ireland | Jun 2012
Consumer Health in Israel | Feb 2012
Consumer Health in Italy | Jul 2012
Consumer Health in Japan | Apr 2012
Consumer Health in Kazakhstan | Apr 2012
Consumer Health in Kenya | Sep 2012
Consumer Health in Latvia | May 2012
Consumer Health in Lithuania | Mar 2012
Consumer Health in Macedonia | May 2012
Consumer Health in Malaysia | May 2012
Consumer Health in Mexico | Feb 2013
Consumer Health in Morocco | Jul 2012
Consumer Health in New Zealand | Mar 2012
Consumer Health in Nigeria | Jul 2012
Consumer Health in Norway | Jun 2012
Consumer Health in Pakistan | Sep 2012
Consumer Health in Peru | Feb 2012
Consumer Health in Poland | May 2012
Consumer Health in Portugal | Sep 2012
Consumer Health in Romania | Nov 2012
Consumer Health in Russia | Mar 2012
Consumer Health in Saudi Arabia | Nov 2012
Consumer Health in Serbia | Jul 2012
Consumer Health in Singapore | Jun 2012
Consumer Health in Slovakia | May 2012
Consumer Health in Slovenia | Oct 2012
Consumer Health in South Africa | May 2012
Consumer Health in South Korea | Aug 2012
Consumer Health in Spain | May 2012
Consumer Health in Sweden | Jun 2012
Consumer Health in Switzerland | Jun 2012
Consumer Health in Taiwan | May 2012
Consumer Health in Thailand | May 2012
Consumer Health in the Czech Republic | Apr 2012
Consumer Health in the Netherlands | Aug 2012
Consumer Health in the Philippines | Jun 2012
Consumer Health in the United Arab Emirates | Feb 2013
Consumer Health in the United Kingdom | Jun 2012
Consumer Health in the US | Apr 2012
Consumer Health in Tunisia | Sep 2011
Consumer Health in Turkey | Apr 2012
Consumer Health in Ukraine | May 2012
Consumer Health in Uruguay | Feb 2012
Consumer Health in Uzbekistan | Aug 2012
Consumer Health in Venezuela | Apr 2012
Consumer Health in Vietnam | Aug 2012

Global Reports

A Global Overview of Herbal/Traditional Products | Feb 2011
A Global Update on OTC Switches | Aug 2010
Consumer Health – Trends, Developments and Prospects | May 2011
Consumer Health - Trends, Developments and Prospects - World | Apr 2010
Consumer Health: Trends, Developments and Prospects | Jun 2012
Corporate Strategies in Consumer Health | Feb 2012
Corporate Strategies in Consumer Health 2010 | Nov 2010
Forecast Revisit 2010-2011 Consumer Health | Dec 2010
Forecast Revisit 2011-2012: Consumer Health | Feb 2012
Generic Drugs in Consumer Health Global Overview 2011 | Jul 2011
Global OTC Healthcare: Adding Value in a Cold Economic Climate | May 2009
Global OTC Healthcare: Resilience to Global Recession | Jul 2009
Global OTC Healthcare: Rx-to-OTC Switches Create New Opportunities | Sep 2009
Global OTC Healthcare: Segmentation and Positioning Create Opportunities in Dietary Supplements | Jul 2009
Keeping Our Children Healthy: A Review of Paediatric Care | Jan 2012
New Product Developments in Consumer Health | Apr 2012
New Product Developments in Consumer Health 2011 | Mar 2011
Pricing and Private Label in Consumer Health | Nov 2010
Regional Overview: Consumer Health Trends in Asia Pacific | Mar 2012
Selling Health: Trends in Marketing and Advertising | Jan 2013
Sports Nutrition – The Evolution of Fitness and Consumers | Jun 2010
The Art of Positioning Dietary Supplements | May 2012
The Power of the Consumer: How the Consumer Health Industry Can Succeed with the Next Generation of Consumers | Oct 2010
The Shapes and Sizes of Recovery in 2010 | Jun 2010
Trends and Opportunities in Single Vitamins | Jun 2010
Understanding Weight Management in 2011 and Beyond | Oct 2011
Value Redefined? Finding a Winning Formula in the Midst of Economic Downturn | Dec 2009
Vitamins and Dietary Supplements - Trends and Prospects 2011 | Jun 2011
Vitamins and Dietary Supplements Regulation Update | Oct 2010

Company Reports

Amway Corp in Consumer Health | Aug 2011
Bayer AG in Consumer Health | Jun 2012
Beiersdorf AG in OTC Healthcare | Aug 2009
Boehringer Ingelheim in Consumer Health | Oct 2011
Bristol-Myers Squibb Co in Consumer Health | Jun 2011
General Nutrition Centers Inc in Consumer Health | Mar 2012
GlaxoSmithKline Plc in Consumer Health | Sep 2012
Herbalife Ltd in Consumer Health | Jul 2011
Johnson & Johnson Inc in Consumer Health | Aug 2012
Merck & Co Inc in Consumer Health | May 2012
Merck KGaA in Consumer Health | May 2012
NBTY Inc in Consumer Health | Jul 2012
Novartis AG in Consumer Health | Jun 2012
Nu Skin Enterprises Inc in Consumer Health | Aug 2011
Otsuka Holdings Co Ltd in Consumer Health | Oct 2012
Otsuka Pharmaceutical Co Ltd in Consumer Health | Aug 2010
Pfizer Inc in Consumer Health | Mar 2012
Procter & Gamble Co,The in Consumer Health | Sep 2012
Reckitt Benckiser Plc in Consumer Health | Sep 2012
Sanofi in Consumer Health | Jul 2012
Sanofi-Aventis in Consumer Health | Sep 2011
Taisho Pharmaceutical Co Ltd in Consumer Health | Sep 2011

About Us
Products
Consulting
Press
Join Us
- Twitter
- LinkedIn
- Facebook
- YouTube

© 2013 Euromonitor is privately owned and trademarked under these terms and conditions. Privacy Policy